Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,748,105 papers from all fields of science
Search
Sign In
Create Free Account
Complement dependent cytotoxicity
Known as:
CDC
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Complement-Dependent Cytotoxicity
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
A positive complement dependent cytotoxicity immunoglobulin G crossmatch due to auto-antibodies with a negative luminex bead assays in a renal transplant recipient: A Diagnostic dilemma
M. Chowdhry
,
R. Makroo
,
B. Kakkar
,
Y. Thakur
,
M. Kumar
,
Mandhata Singh
Asian Journal of Transfusion Science
2018
Corpus ID: 58959880
Transplant recipients are always at a risk of developing anti-human leukocyte antigen (HLA) antibodies due to prior sensitizing…
Expand
2016
2016
Valor De La Prueba Cruzada Virtual En El Programa De Selección De Receptores De Trasplante Renal Modalidad Donante Fallecido En Panamá.
A. Vernaza-Kwiers
,
J. Moscoso
,
+4 authors
C. Viggiano
2016
Corpus ID: 192926227
Resumen El establecer parametros reales pre-trasplante para determinar el riesgo de rechazo inmuno-logico, ha sido uno de los…
Expand
2013
2013
Immunoglobulin G subclass analysis of HLA donor specific antibodies in heart and renal transplant recipients.
J. Cicciarelli
,
N. Kasahara
,
+4 authors
S. Steinberg
Clinical transplants
2013
Corpus ID: 482834
Immunoglobulin G (IgG) subclasses IgG1 (G1) and lgG3 (G3) can induce complement dependent cytotoxicity (CDC) and bind to Fc…
Expand
Review
2013
Review
2013
MONOCLONAL ANTIBODIES WITH ADCC AND CDC ENHANCEMENT FOR THERAPY
Kolla Bramhendra Choudary
2013
Corpus ID: 15671146
Monoclonal antibodies are highly specific molecular-targeted therapeutic agents and represent fastest growing areas of the…
Expand
2013
2013
Post Transplant Human Cytomegalovirus Infection Can Provoke Acute Kidney Allograft Rejection
Arpita Ghosh
,
Sushmita Jha
,
Nasifa Hasan
,
Sumit Das
,
S. Roy
2013
Corpus ID: 75523435
Human Cytomegalovirus (HCMV) infection can trigger immunological cascades leading to kidney allograft rejection. In this study we…
Expand
2013
2013
MLabs Spectrum Evolution and Present Role of the Histocompatibility Laboratory in Solid Organ Transplantation
2013
Corpus ID: 53507367
The foundational event that introduced the Histocompatibility Laboratory into Clinical Pathology was a report by Patel and…
Expand
2012
2012
Ofatumumab (OFA) Is a Novel Anti-CD20 Monoclonal Antibody (mAb) with Improved Anti-Tumor Activity in Vitro and in Vivo in Mantle Cell Lymphoma (MCL) Pre-Clinical Models.
M. Barth
,
Gopichand Pendurti
,
+4 authors
F. Hernandez-Ilizaliturri
2012
Corpus ID: 208383827
Abstract 2757 MCL is typically characterized by an aggressive clinical course and inevitable development of refractory disease…
Expand
2008
2008
Antibodies directed against HLA-DR gene products exhibit the CYNAP phenomenon.
H. Gebel
,
J. Oldfather
,
R. Karr
,
T. Fuller
,
G. Rodey
Tissue Antigens
2008
Corpus ID: 2989800
Two well characterized Eighth International Workshop sera, 8w1090 and 8w112 , described to have anti-DR3 and anti-DR5 activity…
Expand
2000
2000
Specific anti-HLA antibody: detection and application
Zhu Zhong-yon
2000
Corpus ID: 75822456
Objective To screen the specific anti HLA IgG antibodies for evaluating sensitization in renal transplantation. Methods 211 sera…
Expand
1979
1979
Antibody dependent cell mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC) in 229 sera from human renal allograft recipients.
B. Descamps
,
R. Gagnon
,
R. van der Gaag
,
M. Feuillet
,
J. Crosnier
Journal of clinical & laboratory immunology
1979
Corpus ID: 42632143
Comparison between CDC and ADCC in a human allogeneic model using the same cytotoxicity marker, i.e. 51Cr release from labelled…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE